404
+1-313-307-4176
Specimen Validity Testing Market Growth Analysis | 2023-2028
Specimen Validity Testing Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2023-2028
The specimen validity testing market was estimated at USD 1.34 billion in 2022 and is likely to grow at a CAGR of 6.39% during 2023-2028 to reach USD 1.95 billion in 2028.
Want to know more about the market scope? Register Here
Specimen validity tests, also known as testing for nitrates or Test Sure, are performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. A drug-testing program detects people who have used drugs. The test determines whether a urine specimen has been adulterated, diluted, or substituted.
Major factors such as increasing illegal drug-related activities, stringent drug-screening regulations, and increasing government investment to combat drug abuse are expected to drive market growth during the forecast period. Furthermore, rising demand for presumptive tests, growing consumption of illicit drugs among the younger generation, and the adoption of drug screening tests at the workplace are all expected to have a significant impact on the demand for the market.
Want to have a closer look at this market report? Click Here
Some of the key players in the market are:
Note: The above list does not necessarily include all the top players in the market.
Are you the leading player in this market? We would love to include your name. Write to us at [email protected]
|
Segmentations |
List of Sub-Segments |
Segments with High Growth Opportunity |
|
Products & Services Type Analysis |
Products {Reagents, Calibrators, and Controls; Assay Kits; and Disposables} and Services |
The reagents, calibrators, and controls sub-segment is expected to dominate the market during the forecast period. |
|
Testing Type Analysis |
Laboratory Testing and Rapid/POC Testing |
Rapid/POC testing is expected to grow at a higher CAGR in the market during the forecast period. |
|
Regional Analysis |
North America, Europe, Asia-Pacific, and Rest of the World |
North America is the dominant region in the market. |
Based on the products & services type, the market is segmented as products and services. The products segment is further sub-segmented as reagents, calibrators, and controls; assay kits; and disposables. The reagents, calibrators, and controls sub-segment is expected to dominate the market during the forecast period, owing to the increasing demand for reagents and rapid screening kits in drug screening laboratories.
Based on the testing type, the market is segmented as laboratory testing and rapid/POC testing. Rapid/POC testing is expected to grow at a higher CAGR in the market during the forecast period. The benefits of instant results, the ability to detect multiple drugs at once, and the recurrent and repetitive use of rapid/POC drug testing products are driving the segment's growth.
In terms of regions, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, North America is the dominant region in the market due to stringent laws for drug screening, increasing government investment to control drug abuse, and an increase in the consumption of illicit drugs. Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.
Know the high-growth countries in this report. Click Here
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.
The specimen validity testing market is segmented into the following categories:
By Products & Services Type
By Testing Type
By End-User Type
By Region
Want to know the most attractive market segments? Register Here
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Market Segmentation
Competitive Benchmarking
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to [email protected].
Specimen validity tests, also known as testing for nitrates or Test Sure, are performed on a urine drug screen specimen to detect substitution, adulteration, or dilution. A drug testing program detects people who have used drugs. The test determines whether a urine specimen has been adulterated, diluted, or substituted.
The specimen validity testing market was estimated at USD 1.34 billion in 2022.
The specimen validity testing market is likely to reach USD 1.95 billion in 2028.
The specimen validity testing market is likely to grow at a CAGR of 6.39% during 2023-2028.
ACM Global Laboratories., Alfa Scientific Designs, Inc., American Bio Medica Corporation, Clinical Reference Laboratory, Inc., GenomeWeb LLC., Laboratory Corporation of America, Premier Biotech, Inc., Quest Diagnostics Incorporated., Sciteck, Inc., and Thermo Fisher Scientific Inc are among the top players in the market.
The reagents, calibrators, and controls sub-segment is expected to dominate the market in the next five years.
North America is the dominant region in the market.
Increasing illegal drug-related activities, stringent drug-screening regulations, and increasing government investment to combat drug abuse are the factors driving the growth of the market.
WE ACCEPT
